Development and manufacture of orthopedic implants and instruments for joint replacement, sports medicine and spine surgery.
Medacta International S.A.
Castel San Pietro (CH) · Rancate (CH) · Frauenfeld (CH) · Göppingen (DE) · Seekirchen (AT) · Franklin, TN (US) · Sarasota (US) · further subsidiaries worldwideNew on Amplifa
About Medacta
Medacta International S.A. is a Swiss medical technology company founded in 1999 by Dr. Alberto Siccardi, headquartered in Castel San Pietro (Ticino). The company develops and manufactures orthopedic implants and surgical instruments for hip and knee endoprosthetics, spine surgery and sports medicine. The focus is on minimally invasive surgical techniques such as AMIS as well as personalized, patient-specific solutions. Manufacturing includes, among other things, additive manufacturing (3D printing) using the titanium alloy Ti6Al4V (3D Metal) as well as coating technologies such as titanium nitride (SensiTiN) and plasma spraying of titanium (Mectagrip). Medacta is listed on the SIX Swiss Exchange, generated revenue of EUR 683.8 million, employs around 2,165 staff and supplies more than 70 countries worldwide. Production sites and centers of excellence are located in Rancate and Castel San Pietro (Ticino) as well as Frauenfeld.
- Site
- Castel San Pietro
- Processes
- 3D printing / additive manufacturing process (layer-by-layer production, '3D Metal'), Plasma spray coating of titanium (Mectagrip), Titanium nitride coating (SensiTiN), Development of orthopedic implants and instruments, Minimally invasive surgical techniques (AMIS), Personalized solutions (patient-specific instruments), Surgeon education (M.O.R.E. Institute, Medacta TV), 3D printing / additive manufacturing (3D Metal, Ti6Al4V)
- Materials
- Ti6Al4V (titanium alloy, '3D Metal'), Titanium (plasma spray coating, Mectagrip), Titanium nitride (ceramic-like coating, SensiTiN), Ti6Al4V (3D Metal), Titanium plasma spray coating (Mectagrip), Titanium nitride coating (SensiTiN)
- Certificates
- ISO 9001, ISO 13485
- Founded
- 1999
- Employees
- 2165
- Industries
- Orthopedic Surgery (Hip, Knee), Spine Surgery, Sports Medicine, Medical Technology, Orthopedic Surgery (Joint Replacement: Hip, Knee), Spine Surgery (Spine)
- 01
Research & Development
- 02
Additive Manufacturing (3D printing Ti6Al4V)
- 03
Coating technologies (SensiTiN, Mectagrip)
- 04
Surgeon education (M.O.R.E. Institute)
- 05
Distribution to more than 70 countries
Materials & Processes
Ti6Al4V (3D Metal)
Titanium alloy for additively manufactured, bone-friendly implant structures produced layer by layer in a 3D printing process.
Titanium plasma spray coating (Mectagrip)
Plasma-sprayed titanium layer for high initial stability in cementless fixation in hip endoprosthetics.
Titanium nitride coating (SensiTiN)
Ceramic-like titanium nitride coating to reduce the release of metal ions in knee implants.
Sites
Castel San Pietro
CHHeadquarters
- Materials
- Ti6Al4V
Rancate
CHProduction/Hub
- Materials
- Ti6Al4V
Frauenfeld
CHSwiss site
Göppingen
DEMedacta Germany GmbH
Seekirchen
ATMedacta Austria GmbH
Franklin, TN
USMedacta USA, Inc.
Sarasota
USParcus Medical (acquisition 2025, sports medicine)
Industries
Processes & technical limits
| Processes | Tolerance | Max. part | Weight | Lot size | Materials |
|---|---|---|---|---|---|
| 3D printing / additive manufacturing process (layer-by-layer production, '3D Metal')Additive | – | – | – | – | Ti6Al4V (titanium alloy) |
| Plasma spray coating of titanium (Mectagrip)Surface | – | – | – | – | Titanium |
| Titanium nitride coating (SensiTiN)Surface | – | – | – | – | Titanium nitride |
Additional services
Quality
Medacta maintains a comprehensive corporate compliance program; in the USA the company is a member of AdvaMed and follows the AdvaMed Code of Ethics. Certificates such as ISO standards were not specified in the sources evaluated.
| Evidence | Company |
|---|---|
| ISO 9001 | |
| ISO 13485 |
History
- 1999
Medacta is founded by Dr. Alberto Siccardi, inspired by his own experience as an orthopedic patient.
- 2004
Introduction of AMIS, the first minimally invasive hip technique; founding of the M.O.R.E. Institute.
- 2019
IPO on the SIX Swiss Exchange; Francesco Siccardi takes over the CEO role.
- 2024
25th anniversary with the 'World Tour' series of scientific events; substantial investments in the Rancate and Castel San Pietro sites.
- 2025
Acquisition of Parcus Medical (US sports medicine); opening of two new buildings in Rancate and Castel San Pietro to expand capacity.